2XFU - JenaLib

Asym./Biol. Unit (Jmol Viewer)

Asym./Biol. Unit - sites (Jmol Viewer)

Title :   HUMAN MONOAMINE OXIDASE B WITH TRANYLCYPROMINE

Authors :   C. Binda, M. Li, F. Hubalek, N. Restelli, D. E. Edmondson, A. Mattevi

Date :   26 May 10 (Deposition) - 09 Jun 10 (Release) - 24 Nov 10 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   2.20

Chains :   Asym./Biol. Unit : A,B

Keywords :   Flavoprotein, Oxidoreductase (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   C. Binda, M. Li, F. Hubalek, N. Restelli, D. E. Edmondson, A. Mattevi
Insights Into The Mode Of Inhibition Of Human Mitochondrial Monoamine Oxidase B From High- Resolution Crystal Structures.
Proc. Natl. Acad. Sci. Usa V. 100 9750 2003
PubMed-ID: 12913124 | Reference-DOI: 10.1073/PNAS.1633804100
(for further references see the PDB file header)

Molecule 1 - AMINE OXIDASE [FLAVIN-CONTAINING] B
	Chains	:	A, B
	EC Number	:	1.4.3.4
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	MONOAMINE OXIDASE TYPE B, MAO-B

		1	2
Asymmetric/Biological Unit	:	A	B

Summary Information (see also Sequences/Alignments below)

Asymmetric/Biological Unit (2, 4)

No.	Name	Count	Type	Full Name
1	3PL	2	Ligand/Ion	3-PHENYLPROPANAL
2	FA8	2	Ligand/Ion	[[(2R,3S,4S)-5-[(4AS)-7,8-DIMETHYL-2,4-DIOXO-4A,5-DIHYDROBENZO[G]PTERIDIN-10-YL]-2,3,4-TRIHYDROXY-PENTOXY]-HYDROXY-PHOSPHORYL] [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL HYDROGEN PHOSPHATE

Asymmetric Unit (2, 2)

No.	Name	Evidence	Residues	Description
1	AC1	SOFTWARE	GLY A:11 , GLY A:13 , ILE A:14 , SER A:15 , LEU A:33 , GLU A:34 , ALA A:35 , ARG A:36 , GLY A:40 , GLY A:41 , ARG A:42 , THR A:43 , GLY A:57 , GLY A:58 , SER A:59 , TYR A:60 , CYS A:172 , TYR A:188 , GLN A:206 , ARG A:233 , PRO A:234 , VAL A:235 , ALA A:263 , ILE A:264 , TRP A:388 , TYR A:393 , CYS A:397 , TYR A:398 , GLY A:425 , THR A:426 , GLY A:434 , TYR A:435 , MET A:436 , ALA A:439 , HOH A:2001 , HOH A:2175 , HOH A:2176 , HOH A:2177 , HOH A:2178 , HOH A:2179 , HOH A:2180	BINDING SITE FOR CHAIN A OF RESIDUES 600 TO 601
2	AC2	SOFTWARE	VAL B:10 , GLY B:11 , GLY B:13 , ILE B:14 , SER B:15 , LEU B:33 , GLU B:34 , ALA B:35 , ARG B:36 , GLY B:40 , GLY B:41 , ARG B:42 , THR B:43 , GLY B:57 , GLY B:58 , SER B:59 , TYR B:60 , CYS B:172 , TYR B:188 , GLN B:206 , ARG B:233 , PRO B:234 , VAL B:235 , ALA B:263 , ILE B:264 , TRP B:388 , TYR B:393 , CYS B:397 , TYR B:398 , GLY B:425 , THR B:426 , GLY B:434 , TYR B:435 , MET B:436 , ALA B:439 , HOH B:2032 , HOH B:2127 , HOH B:2139 , HOH B:2185 , HOH B:2222 , HOH B:2223 , HOH B:2224 , HOH B:2225	BINDING SITE FOR CHAIN B OF RESIDUES 600 TO 601

(no "SS Bond" information available for 2XFU)

Asymmetric/Biological Unit

No.	Residues
1	Asn A:275	-	Pro A:276
2	Cys A:397	-	Tyr A:398
3	Asn B:275	-	Pro B:276
4	Cys B:397	-	Tyr B:398

(no "SAP(SNP)/Variant" information available for 2XFU)

(no "PROSITE Motif" information available for 2XFU)

Asymmetric/Biological Unit (15, 30)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1a	ENST00000378069	1a	ENSE00001476175	X:43741693-43741500	194	AOFB_HUMAN	1-16	16	2	A:3-16 B:3-16	14 14
1.4	ENST00000378069	4	ENSE00000847672	X:43703010-43702916	95	AOFB_HUMAN	16-47	32	2	A:16-47 B:16-47	32 32
1.5	ENST00000378069	5	ENSE00000386774	X:43698251-43698114	138	AOFB_HUMAN	48-93	46	2	A:48-93 B:48-93	46 46
1.6	ENST00000378069	6	ENSE00001035779	X:43662651-43662547	105	AOFB_HUMAN	94-128	35	2	A:94-128 B:94-128	35 35
1.7	ENST00000378069	7	ENSE00001035776	X:43661510-43661419	92	AOFB_HUMAN	129-159	31	2	A:129-159 B:129-159	31 31
1.8b	ENST00000378069	8b	ENSE00001035764	X:43656513-43656372	142	AOFB_HUMAN	159-206	48	2	A:159-206 B:159-206	48 48
1.9	ENST00000378069	9	ENSE00001035777	X:43655135-43654986	150	AOFB_HUMAN	207-256	50	2	A:207-256 B:207-256	50 50
1.10	ENST00000378069	10	ENSE00001035772	X:43652825-43652666	160	AOFB_HUMAN	257-310	54	2	A:257-310 B:257-310	54 54
1.11	ENST00000378069	11	ENSE00001035775	X:43640791-43640695	97	AOFB_HUMAN	310-342	33	2	A:310-342 B:310-342	33 33
1.12	ENST00000378069	12	ENSE00001035768	X:43639642-43639589	54	AOFB_HUMAN	342-360	19	2	A:342-360 B:342-360	19 19
1.13	ENST00000378069	13	ENSE00001035781	X:43637986-43637929	58	AOFB_HUMAN	360-379	20	2	A:360-379 B:360-379	20 20
1.14	ENST00000378069	14	ENSE00001700569	X:43634519-43634422	98	AOFB_HUMAN	380-412	33	2	A:380-412 B:380-412	33 33
1.15a	ENST00000378069	15a	ENSE00001712216	X:43628665-43628554	112	AOFB_HUMAN	412-449	38	2	A:412-449 B:412-449	38 38
1.16	ENST00000378069	16	ENSE00000668638	X:43627963-43627901	63	AOFB_HUMAN	450-470	21	2	A:450-470 B:450-470	21 21
1.17b	ENST00000378069	17b	ENSE00001332403	X:43626865-43625858	1008	AOFB_HUMAN	471-520	50	2	A:471-501 B:471-496	31 26

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:499
 aligned with AOFB_HUMAN | P27338 from UniProtKB/Swiss-Prot  Length:520

    Alignment length:499
                                    12        22        32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462       472       482       492         
           AOFB_HUMAN     3 NKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTI 501
               SCOP domains d2xfua1 A:3-289,A:402-501 Monoamine oxidase B                                                                                                                                                                                                                                                  d2xfua2 A:290-401 Monoamine oxidase B                                                                           d2xfua1 A:3-289,A:402-501 Monoamine oxidase B                                                        SCOP domains
               CATH domains 2xfuA01                                2xfuA02              2xfuA01         2xfuA02                      2xfuA03 A:108-199 Guanine Nucleotide Dissociation Inhibitor, domain 1                       2xfuA02    2xfuA01 A:3-41,A:63-78,A:211-289,A:403-463  [code=3.50.50.60, no name defined] 2xfuA02 A:42-62,A:79-107,A:200-210,A:290-402  [code=3.90.660.10, no name defined]                                2xfuA01 A:3-41,A:63-78,A:211-289,A:403-463                   -------------------------------------- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....eeee..hhhhhhhhhhhhhh...eeee...........ee.......ee....ee...hhhhhhhhhhh...eee.....eeeeee..eeeee........hhhhhhhhhhhhhhhhhhhh.....hhhhh.hhhhhhh.hhhhhhhhhh.hhhhhhhhhhhhhhhhh......hhhhhhhhhhhh.hhhhhhh.......eee...hhhhhhhhhhhhh..ee....eeeee.....eeeee....eeee.eeee..hhhhhhhheee...hhhhhhhh.......eeeeeee...hhhhhh.eeeeeee........eeee.........eeeeeeehhhhhhhh..hhhhhhhhhhhhhhhhh.hhhhhh..eeeeee.hhh.............hhhhhhhhhh......eee.hhhhh.....hhhhhhhhhhhhhhhhhhhh...hhhhh.................hhhhhhh.hhhhhhhhhhhhh. Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.1a     -------------------------------Exon 1.5  PDB: A:48-93 UniProt: 48-93         Exon 1.6  PDB: A:94-128            Exon 1.7  PDB: A:129-159       -----------------------------------------------Exon 1.9  PDB: A:207-256 UniProt: 207-256         Exon 1.10  PDB: A:257-310 UniProt: 257-310            -------------------------------Exon 1.12          -------------------Exon 1.14  PDB: A:380-412        -------------------------------------Exon 1.16            Exon 1.17b  PDB: A:471-501      Transcript 1 (1)
           Transcript 1 (2) -------------Exon 1.4  PDB: A:16-47          ---------------------------------------------------------------------------------------------------------------Exon 1.8b  PDB: A:159-206 UniProt: 159-206      -------------------------------------------------------------------------------------------------------Exon 1.11  PDB: A:310-342        -----------------Exon 1.13           --------------------------------Exon 1.15a  PDB: A:412-449            ---------------------------------------------------- Transcript 1 (2)
                 2xfu A   3 NKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTI 501
                                    12        22        32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462       472       482       492

Chain B from PDB  Type:PROTEIN  Length:494
 aligned with AOFB_HUMAN | P27338 from UniProtKB/Swiss-Prot  Length:520

    Alignment length:494
                                    12        22        32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462       472       482       492    
           AOFB_HUMAN     3 NKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLI 496
               SCOP domains d2xfub1 B:3-289,B:402-496 Monoamine oxidase B                                                                                                                                                                                                                                                  d2xfub2 B:290-401 Monoamine oxidase B                                                                           d2xfub1 B:3-289,B:402-496 Monoamine oxidase B                                                   SCOP domains
               CATH domains 2xfuB01                                2xfuB02              2xfuB01         2xfuB02                      2xfuB03 B:108-199 Guanine Nucleotide Dissociation Inhibitor, domain 1                       2xfuB02    2xfuB01 B:3-41,B:63-78,B:211-289,B:403-463  [code=3.50.50.60, no name defined] 2xfuB02 B:42-62,B:79-107,B:200-210,B:290-402  [code=3.90.660.10, no name defined]                                2xfuB01 B:3-41,B:63-78,B:211-289,B:403-463                   --------------------------------- CATH domains
           Pfam domains (1) -----------Amino_oxidase-2xfuB01 B:14-451                                                                                                                                                                                                                                                                                                                                                                                                                        --------------------------------------------- Pfam domains (1)
           Pfam domains (2) -----------Amino_oxidase-2xfuB02 B:14-451                                                                                                                                                                                                                                                                                                                                                                                                                        --------------------------------------------- Pfam domains (2)
         Sec.struct. author ....eeee..hhhhhhhhhhhhhh...eeee...........ee.......ee....ee...hhhhhhhhhhh...eee.....eeeeee..eeeee........hhhhhhhhhhhhhhhhhhhh.....hhhhh.hhhhhhh.hhhhhhhhhh.hhhhhhhhhhhhhhhhh......hhhhhhhhhhh..hhhhhhh.......eee...hhhhhhhhhhhhh..ee....eeeee.....eeeee....eeee.eeee..hhhhhhhheee...hhhhhhhh.......eeeeeee...hhhhhh.eeeeeee........eeee.........eeeeeeehhhhhhhh..hhhhhhhhhhhhhhhhhhhhhhhh..eeeeee.hhh.............hhhhhhhhhh......eee.hhhhh.....hhhhhhhhhhhhhhhhhhhh...hhhhh.................hhhhhhh.hhhhhhhh. Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.1a     -------------------------------Exon 1.5  PDB: B:48-93 UniProt: 48-93         Exon 1.6  PDB: B:94-128            Exon 1.7  PDB: B:129-159       -----------------------------------------------Exon 1.9  PDB: B:207-256 UniProt: 207-256         Exon 1.10  PDB: B:257-310 UniProt: 257-310            -------------------------------Exon 1.12          -------------------Exon 1.14  PDB: B:380-412        -------------------------------------Exon 1.16            Exon 1.17b  PDB: B:471-496 Transcript 1 (1)
           Transcript 1 (2) -------------Exon 1.4  PDB: B:16-47          ---------------------------------------------------------------------------------------------------------------Exon 1.8b  PDB: B:159-206 UniProt: 159-206      -------------------------------------------------------------------------------------------------------Exon 1.11  PDB: B:310-342        -----------------Exon 1.13           --------------------------------Exon 1.15a  PDB: B:412-449            ----------------------------------------------- Transcript 1 (2)
                 2xfu B   3 NKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLI 496
                                    12        22        32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462       472       482       492

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Asymmetric/Biological Unit

Classes(

)

Folds(

)

Superfamilies( (-)

)

Families(

)

Protein Domains( (-)

)

Organisms( (-)

)

Class: Alpha and beta proteins (a+b) (23004)

Fold: FAD-linked reductases, C-terminal domain (181)

Superfamily: FAD-linked reductases, C-terminal domain (181)

Family: L-aminoacid/polyamine oxidase (66)

Protein domain: Monoamine oxidase B (38)

Human (Homo sapiens) [TaxId: 9606] (37)

1a	d2xfua2	A:290-401
1b	d2xfub2	B:290-401

Class: Alpha and beta proteins (a/b) (23833)

Fold: FAD/NAD(P)-binding domain (331)

Superfamily: FAD/NAD(P)-binding domain (331)

Family: FAD-linked reductases, N-terminal domain (156)

Protein domain: Monoamine oxidase B (38)

Human (Homo sapiens) [TaxId: 9606] (37)

2a	d2xfua1	A:3-289,A:402-501
2b	d2xfub1	B:3-289,B:402-496

Asymmetric/Biological Unit

Classes(

)

Architectures( (-)

)

Topologies( (-)

)

Homologous Superfamilies( (-)

)

Organisms( (-)

)

Class: Alpha Beta (26913)

Architecture: 3-Layer(bba) Sandwich (528)

Topology: FAD/NAD(P)-binding domain (373)

Homologous Superfamily: [code=3.50.50.60, no name defined] (373)

Human (Homo sapiens) (57)

1a	2xfuA01	A:3-41,A:63-78,A:211-289,A:403-463
1b	2xfuB01	B:3-41,B:63-78,B:211-289,B:403-463

Architecture: Alpha-Beta Complex (3881)

Topology: Polyamine Oxidase; Chain A, domain 2 (62)

Homologous Superfamily: [code=3.90.660.10, no name defined] (61)

Human (Homo sapiens) (29)

2a	2xfuA02	A:42-62,A:79-107,A:200-210,A:290-402
2b	2xfuB02	B:42-62,B:79-107,B:200-210,B:290-402

Class: Mainly Alpha (13335)

Architecture: Orthogonal Bundle (10391)

Topology: Guanine Nucleotide Dissociation Inhibitor; domain 1 (50)

Homologous Superfamily: Guanine Nucleotide Dissociation Inhibitor, domain 1 (50)

Human (Homo sapiens) (29)

3a	2xfuA03	A:108-199
3b	2xfuB03	B:108-199

Asymmetric/Biological Unit

Clans(

)

Families(

)

Organisms( (-)

)

Clan: NADP_Rossmann (1239)

Family: Amino_oxidase (60)

Homo sapiens (Human) (37)

1a	Amino_oxidase-2xfuB01	B:14-451
1b	Amino_oxidase-2xfuB02	B:14-451

Asymmetric/Biological Unit(hide GO term definitions)

Chain A,B (AOFB_HUMAN | P27338)

molecular function
	GO:0009055	electron carrier activity	Any molecular entity that serves as an electron acceptor and electron donor in an electron transport chain. An electron transport chain is a process in which a series of electron carriers operate together to transfer electrons from donors to any of several different terminal electron acceptors to generate a transmembrane electrochemical gradient.
	GO:0050660	flavin adenine dinucleotide binding	Interacting selectively and non-covalently with FAD, flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes, in either the oxidized form, FAD, or the reduced form, FADH2.
	GO:0016491	oxidoreductase activity	Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
	GO:0008131	primary amine oxidase activity	Catalysis of the reaction: a primary amine + H2O + O2 = an aldehyde + NH3 + hydrogen peroxide.
	GO:0042803	protein homodimerization activity	Interacting selectively and non-covalently with an identical protein to form a homodimer.
biological process
	GO:0042420	dopamine catabolic process	The chemical reactions and pathways resulting in the breakdown of dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline.
	GO:0050665	hydrogen peroxide biosynthetic process	The chemical reactions and pathways resulting in the formation of hydrogen peroxide (H2O2), a potentially harmful byproduct of aerobic cellular respiration which can cause damage to DNA.
	GO:0014063	negative regulation of serotonin secretion	Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of serotonin.
	GO:0055114	oxidation-reduction process	A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.
	GO:0045964	positive regulation of dopamine metabolic process	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving dopamine.
	GO:0010044	response to aluminum ion	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an aluminum ion stimulus.
	GO:0051412	response to corticosterone	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosterone stimulus. Corticosterone is a 21 carbon steroid hormone of the corticosteroid type, produced in the cortex of the adrenal glands. In many species, corticosterone is the principal glucocorticoid, involved in regulation of fuel metabolism, immune reactions, and stress responses.
	GO:0042493	response to drug	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
	GO:0045471	response to ethanol	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.
	GO:0032496	response to lipopolysaccharide	Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
	GO:0010269	response to selenium ion	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from selenium ion.
	GO:0048545	response to steroid hormone	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a steroid hormone stimulus.
	GO:0009636	response to toxic substance	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus.
	GO:0021762	substantia nigra development	The progression of the substantia nigra over time from its initial formation until its mature state. The substantia nigra is the layer of gray substance that separates the posterior parts of the cerebral peduncles (tegmentum mesencephali) from the anterior parts; it normally includes a posterior compact part with many pigmented cells (pars compacta) and an anterior reticular part whose cells contain little pigment (pars reticularis).
cellular component
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0016021	integral component of membrane	The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005740	mitochondrial envelope	The double lipid bilayer enclosing the mitochondrion and separating its contents from the cell cytoplasm; includes the intermembrane space.
	GO:0005743	mitochondrial inner membrane	The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae.
	GO:0005741	mitochondrial outer membrane	The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.
	GO:0005739	mitochondrion	A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.

Asymmetric/Biological Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		3PL	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		FA8	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Asn A:275 - Pro A:276	[ RasMol ]
		Asn B:275 - Pro B:276	[ RasMol ]
		Cys A:397 - Tyr A:398	[ RasMol ]
		Cys B:397 - Tyr B:398	[ RasMol ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym./Biol. Unit PNG format \| Asym./Biol. Unit - sites PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	2xfu
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	AOFB_HUMAN \| P27338
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	1.4.3.4
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	(no 'MIM ID' available)
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	AOFB_HUMAN \| P27338
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

1gos	HUMAN MONOAMINE OXIDASE B
1h8r	HUMAN MONOAMINE OXIDASE TYPE B (TRUNCATED)
1oj9	HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 1,4-DIPHENYL-2-BUTENE
1oja	HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH ISATIN
1ojc	HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE
1ojd	HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH LAURYLDIMETHYLAMINE-N-OXIDE (LDAO)
1s2q	CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-PROPARGYL-1(R)-AMINOINDAN (RASAGILINE)
1s2y	CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-PROPARGYL-1(S)-AMINOINDAN
1s3b	CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-METHYL-N-PROPARGYL-1(R)-AMINOINDAN
1s3e	CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH 6-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN
2bk3	HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH FARNESOL
2bk4	HUMAN MONOAMINE OXIDASE B: I199F MUTANT IN COMPLEX WITH RASAGILINE
2bk5	HUMAN MONOAMINE OXIDASE B: I199F MUTANT IN COMPLEX WITH ISATIN
2byb	HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH DEPRENYL
2c64	MAO INHIBITION BY RASAGILINE ANALOGUES
2c65	MAO INHIBITION BY RASAGILINE ANALOGUES
2c66	MAO INHIBITION BY RASAGILINE ANALOGUES
2c67	MAO INHIBITION BY RASAGILINE ANALOGUES
2c70	FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS
2c72	FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS
2c73	FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS
2c75	FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS
2c76	FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS
2v5z	STRUCTURE OF HUMAN MAO B IN COMPLEX WITH THE SELECTIVE INHIBITOR SAFINAMIDE
2v60	STRUCTURE OF HUMAN MAO B IN COMPLEX WITH THE SELECTIVE INHIBITOR 7-(3-CHLOROBENZYLOXY )-4-CARBOXALDEHYDE-COUMARIN
2v61	STRUCTURE OF HUMAN MAO B IN COMPLEX WITH THE SELECTIVE INHIBITOR 7-(3-CHLOROBENZYLOXY )-4-(METHYLAMINO)METHYL-COUMARIN
2vrl	STRUCTURE OF HUMAN MAO B IN COMPLEX WITH BENZYLHYDRAZINE
2vrm	STRUCTURE OF HUMAN MAO B IN COMPLEX WITH PHENYETHYLHYDRAZINE
2vz2	HUMAN MAO B IN COMPLEX WITH MOFEGILINE
2xcg	TRANYLCYPROMINE-INHIBITED HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 2-(2- BENZOFURANYL)-2-IMIDAZOLINE
2xfn	HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 2-(2-BENZOFURANYL)-2-IMIDAZOLINE
2xfo	TRANYLCYPROMINE-INHIBITED HUMAN MONOAMINE OXIDASE B ILE199ALA MUTANT IN COMPLEX WITH 2-(2-BENZOFURANYL)-2-IMIDAZOLINE
2xfp	ISATIN-INHIBITED HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 2-(2-BENZOFURANYL)-2- IMIDAZOLINE
2xfq	RASAGILINE-INHIBITED HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 2-(2-BENZOFURANYL)-2- IMIDAZOLINE

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (2, 4)

Sites (2, 2)

SS Bonds (0, 0)

Cis Peptide Bonds (4, 4)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (0, 0)

PROSITE Motifs (0, 0)

Exons (15, 30)

Sequences/Alignments

Classification and Annotation

SCOP Domains (2, 4)

CATH Domains (3, 6)

Pfam Domains (1, 2)

Gene Ontology (26, 26)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File